Brachytherapy News and Research

RSS

Brachytherapy is a minimally invasive procedure that involves the use of radioactive seeds the size of rice grains. Brachytherapy, an out-patient procedure, usually takes 45 minutes to an hour to perform. Most patients can return to their normal activities within days. The success rates of prostate brachytherapy have compared favorably with success rates of radical prostatectomy and external beam radiation. In comparison studies, prostate brachytherapy has shown to have a favorable side effect profile when compared with other modalities. Clinical studies have shown that prostate brachytherapy has a cure rate of 94% for appropriately selected patients.

Medical mistrust can make African Americans to regret their choice of treatment for prostate cancer

Medical mistrust is one reason why African American patients are more likely to have regrets about their choice of treatment for prostate cancer.

25 Nov 2020

Researchers report outcomes of salvage low dose RT brachytherapy after EBRT for prostate cancer

Researchers involved in the phase II NRG Oncology RTOG 0526 trial studying low dose rate (LDR) prostate brachytherapy (BT) following local recurrence (LR) after external beam radiotherapy (EBRT) for patients with low-to-intermediate risk prostate cancer reported late Grade 3 gastrointestinal and genitourinary adverse events (AEs) occurring in 14% of trial participants.

28 Oct 2020

Combination of antibodies and internal radiation can help fight cervical cancer

The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy.

16 Jun 2020

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

A new clinical guideline from the American Society for Radiation Oncology provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer.

10 Jun 2020

Study evaluates the impact of prostate cancer treatment decisions

A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.

27 Jan 2020

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Newly diagnosed prostate cancer patients have multiple standard-of-care treatment options available, but many are not fully informed of their choices.

19 Nov 2019

ASTRO and ACR release updated practice parameters for radiation therapy

The American Society for Radiation Oncology and the American College of Radiology recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer.

22 Oct 2019

Using X-ray-nanoparticle interactions for improved radiation therapy

A new study has indicated a new way to deliver locally aggressive radiation therapy in cancer, using the element gadolinium.

30 Sep 2019

Cosmetic appearance after skin cancer therapy may differ based on treatment type

While there are several effective options for treating non-melanoma skin cancers, some may result in better cosmetic appearance after treatment, according to researchers.

4 Sep 2019

World’s first clinical guidance on anal sex after prostate cancer treatments

UK doctors and surgeons have formulated what is probably the world's first clinical guidance on anal sex before, during, and after diagnosis and treatment for prostate cancer.

10 Jun 2019

Single high dose of radiation targeted directly to tumor is safe and effective for prostate cancer

A single high dose of radiation that can be delivered directly to the tumor within a few minutes is a safe and effective technique for treating men with low risk prostate cancer, according to a study presented at the ESTRO 38 conference.

29 Apr 2019

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Women with early, low risk, hormone-driven breast cancer are less likely to have a recurrence of their disease if they have radiotherapy after surgery, as well as anti-hormone treatment, according to results from a trial that has followed 869 women for ten years.

26 Apr 2019

New technology provides clearer picture to clinicians treating gynecological cancer

New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynecological cancers, including vaginal, cervical and uterine cancer.

9 Apr 2019

UMGCCC uses Gammapod radiotherapy to treat breast cancer patients

Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer.

6 Dec 2018

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Interstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR).

20 Nov 2018

NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach

Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.

16 Nov 2018

Patient-reported data confirms efficacy of brachytherapy alone in intermediate risk prostate cancer

Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy to transperineal interstitial permanent brachytherapy alone indicate a significantly different clinician and patient-reported late toxicity profile between arms despite similarities in progression-free survival results.

22 Oct 2018

$New guideline supports hypofractionated radiation therapy for men with prostate cancer$

New guideline supports hypofractionated radiation therapy for men with prostate cancer

Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most common malignancy among American men.

12 Oct 2018

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

A robot could become the 'weapon' of choice for detecting and treating the most common cancer in men, improving results and reducing side effects.

4 Oct 2018

RaySearch and Eckert & Ziegler BEBIG sign partnership agreement regarding brachytherapy

RaySearch and Eckert & Ziegler BEBIG, a leading European supplier of brachytherapy products, have signed a partnership agreement. Both the RayStation treatment planning system and the RayCare oncology information system will be integrated with the Eckert & Ziegler BEBIG brachytherapy systems.

From RaySearch Laboratories AB 4 Jul 2018